Results 231 to 240 of about 263,481 (319)

A Cross-sectional Prospective Study of Pleural Effusion Among Cases of Chronic Kidney Disease

, 2022
Subhasis Mukherjee, S. Mitra, Souvik Ray, Joydeep Ganguly, Kumar Abhishek, Somenath Kundu   +5 more
openalex   +1 more source

Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer

World Journal of Surgery, EarlyView.
Aim of this study is to evaluate the prognostic role of nodal parameter in early stage pathologically patients with N0 who underwent lobectomy and lymphadenectomy. Clinical and pathological characteristics of patients who underwent anatomical lung resection from 1/01/2010 to 31/12/2019 were reviewed and retrospectively analyzed.
Marco Chiappetta, Carolina Sassorossi, Filippo Lococo, Elisa Meacci, Maria Teresa Congedo, Jessica Evangelista, Annalisa Campanella, Giuseppe Calabrese, Alessia Senatore, Isabella Sperduti, Stefano Margaritora   +10 more
wiley   +1 more source

Advances and controversies in pleural diseases.

, 2015
José M. Porcel, Georgios Statophoulos, Gary Lee   +2 more
openalex   +1 more source

A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model‐Based Economic Evaluation

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To assess the costs and consequences of seven diagnostic strategies for ovarian cancer in pre‐ and post‐menopausal women with symptoms in secondary care. Design Economic evaluation alongside a prospective single‐arm diagnostic accuracy study.
Samuel J. Perry, Donal Griffin, Eleanor V. Williams, Tracy E. Roberts, Fong Lien Kwong, Sarah Williams, Jon Deeks, Katie Scandrett, Ridhi Agarwal, Sudha S. Sundar, Mark Monahan   +10 more
wiley   +1 more source

Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion. [PDF]

Am J Respir Crit Care Med, 2020
Mytinger A, Taylor T, Gershman E, Shojaee S.   +3 more
europepmc   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Asbestos-Related Pleural Diseases: The Role of Gene-Environment Interactions

, 2019
Vita Dolžan, Alenka Franko
openalex   +2 more sources

Pleural fluid analysis of lung cancer vs benign inflammatory disease patients [PDF]

, 2010
Richard Kremer, Lael Anson Best, Dana Savulescu, Moshe Gavish, Rafael M. Nagler   +4 more
openalex   +1 more source

Global Emergency Medicine: A Scoping Review of the Literature From 2024

Academic Emergency Medicine, EarlyView.
ABSTRACT Objective The Global Emergency Medicine Literature Review (GEMLR) identifies impactful research in global emergency care. This 20th annual edition reviews GEM literature published in 2024 and highlights the growth of GEMLR over the years. Methods We conducted a scoping review of 2024 GEM articles through structured PubMed and gray literature ...
J. Austin Lee, Nana Serwaa A. Quao, Amanda Collier, Chris A. Rees, Morgan C. Broccoli, Nanaba A. Dawson‐Amoah, Vinay N. Kampalath, Joseph Ciano, Ashley Jacobson, Jennifer Jones, Joseph Leanza, Branden Skarpiak, Jonathan M. Strong, Braden J. Hexom, Global Emergency Medicine Literature Review (GEMLR) Group, Abdirahman Abdulle, Halley J. Alberts, Kimonia Bih Awanchiri, Emily Bartlett, Tal Berkowitz, Nidhi Bhaskar, Corey B. Bills, Joseph Bonney, Morgan C. Broccoli, Agatha Brzezinski, Whitney K. Bryant, Jonathan Chan, Joseph D. Ciano, Cassandra Clay, Ly Cloessner, Amanda Collier, Nanaba A. Dawson‐Amoah, Kamoga Dickson, Jonathan W. Dyal, Christian Engelen, Brandon Friedman, Stephanie Chow Garbern, Juliette Gerardo, Mindi Guptill, Reid Haflich, Alison S. Hayward, Braden J. Hexom, Taylor S. Hickey, Anneka Hooft, Emmanuel Oluyinka Idowu, Ashley A. Jacobson, Aqeel Jawahir, Jennifer E. Jones, Vinay N. Kampalath, Elizabeth M. Keating, Sean M. Kivlehan, Arthi S. Kozhumam, Colleen E. Laurence, Joseph Leanza, Samuel Lewis, J. Austin Lee, Gideon Loevinsohn, Parker Maddox, Mallika Manyapu, Michael Mathelier, Kevin J. Mercer, Rmaah Memon, Kevin Molyneux, Dana Naamani, Benjamin D. Nicholson, Hannah Ofosua Owusu, Gerard M. O’Reilly, Mayur Patel, Nana Serwaa Agyeman Quao, Sarah Rapaport, Chris A. Rees, Charlotte Roy, Megan M. Rybarczyk, Jessica Schmidt, Megan L. Schultz, Anand Selvam, Erin F. Shufflebarger, Yusra Shakil, Branden Skarpiak, Cheyenne Smith, Jonathan M. Strong, Janet Jebichii Sugut, Fadhila Tekka, W. Tyler Winders, Ann Wolski, Natalie Yabalwashi   +85 more
wiley   +1 more source

Real‐World Survival Outcomes of Patients With High PD‐L1 Advanced NSCLC Who Received Chemoimmunotherapy Versus Immunotherapy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Are two drugs better than one in advanced NSCLC? ABSTRACT Background Randomized studies have demonstrated superior overall survival (OS) of pembrolizumab (pembro), both alone and in combination with chemotherapy (chemo) over chemo alone in patients with programmed cell death ligand‐1 (PD‐L1) ≥ 50% advanced non–small cell lung cancer (NSCLC).
Junipearl Cheng, Charlotte McKay, Victoria Bray, Po Yee Yip, Annette Tognela, Peey Sei Kok   +5 more
wiley   +1 more source